Biogen's Early-Stage Alzheimer's Data Continues to Impress Post author:Sam Post published:November 1, 2017 Post category:BioPharma ALZ’s researchers continue to see hope in Biogen’s aducanumab. Source: BioSpace You Might Also Like Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017 TraceLink, Inc. Announces End-To-End Administration For Product Track, Alleviating Time-Intensive DSCSA Compliance Tasks For U.S. Hospitals And Pharmacies June 25, 2017 SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017
Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017
TraceLink, Inc. Announces End-To-End Administration For Product Track, Alleviating Time-Intensive DSCSA Compliance Tasks For U.S. Hospitals And Pharmacies June 25, 2017
SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017
